IDR 50.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 81.71 Billion IDR | -12.44% |
2022 | 93.32 Billion IDR | -72.4% |
2021 | 338.12 Billion IDR | 7.9% |
2020 | 313.37 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 11.64 Billion IDR | -56.56% |
2024 Q1 | 26.79 Billion IDR | -17.0% |
2023 Q2 | 5.87 Billion IDR | 52.61% |
2023 FY | 81.71 Billion IDR | -12.44% |
2023 Q1 | 3.85 Billion IDR | 0.0% |
2022 FY | 93.32 Billion IDR | -72.4% |
2021 FY | 338.12 Billion IDR | 7.9% |
2020 FY | 313.37 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Mark Dynamics Indonesia Tbk | 559.46 Billion IDR | 85.394% |
PT Hetzer Medical Indonesia Tbk | 22.72 Billion IDR | -259.622% |
PT Jayamas Medica Industri Tbk | 1736.98 Billion IDR | 95.295% |